Peter Attia· MD
when you describe that Appo E4 was a 20-fold risk and became smaller and smaller well became smaller at home and how their lives were different than those that we knew 20 and 40 years ago that have the APO E4 genotype right
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
when you describe that Appo E4 was a 20-fold risk and became smaller and smaller well became smaller at home and how their lives were different than those that we knew 20 and 40 years ago that have the APO E4 genotype right
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.